Market Flash

The World Health Organization has issued a renewed global call for governments to sharply raise taxes on sugary drinks and alcoholic beverages, warning that weak fiscal policies are quietly fueling a worldwide surge in obesity, diabetes, cardiovascular di

From the U.S. FDA’s progressive approach to drug labeling to European market pressures confronting legacy drugmakers, the landscape is shifting beneath industry feet.

The Australian agricultural trade landscape is once again at the center of international scrutiny as authorities initiated a formal anti-circumvention investigation concerning imports of the widely used herbicide 2,4-D from China.

January 9, 2026 — In a sweeping account of industry transformation, global agricultural markets witnessed a pronounced surge in mergers and acquisitions within the bio-solutions arena during 2025.

Nestlé’s global headquarters sits in Vevey, Switzerland, beside placid lake waters—a picture of calm that outsiders often mistake for an unshakable consumer empire, “too stable to ever capsize.” Yet it was precisely within this company, which prizes equil

President and CEO Michael Hansen will step down to become President and CEO of DFDS, a European ferry and logistics giant. Until a new CEO is appointed, he will continue working with the management team to advance the group’s strategic agenda and will for

Arkema has commenced operations at a large new production facility in Singapore, significantly expanding its market share in high-performance transparent polymers and solidifying its leading position in the Asian market.

• Arkema

Kemira, a leading global provider of sustainable chemical solutions for water-intensive industries, has completed its acquisition of AquaBlue, a privately held company in Ohio, USA.

• Kemira
• AquaBlue

In early 2026, while the global coatings and specialty chemicals industry remained preoccupied with volatile raw material prices, geopolitical risks, and the pressures of green transition, a quiet but pivotal move was made by an “invisible giant” that qui

Saint-Gobain has taken a significant step to reinforce its position in Indonesia’s construction chemicals market.

• Saint-Gobain

In early 2026, China’s chemical sector stands at the epicenter of a silent storm. On one side, Beijing loudly champions its “anti-overcapacity” campaign, urging firms to voluntarily cut output and exit low-end competition.

Singapore-based chemical group Indorama Corporation recently announced that its subsidiary has signed a definitive agreement with Asian private equity firm PAG to acquire 100% ownership of Anyang Zhongying Fertilizer and Anyang Yingde Gas.

• Indorama
• Anyang Zhongying Fertilizer

With the patent expiry of semaglutide—the active ingredient behind blockbuster drugs like Ozempic and Wegovy—in India, select regulated markets, and emerging economies, a massive revenue opportunity exceeding ₹50,000 crore (approximately $6 billion) has o

European Commission officially authorized four genetically modified (GM) crops for import and processing on December 16, 2025—while maintaining its long-standing ban on their cultivation within EU territory.

As the calendar turns to 2026, the global carbon fiber market is entering a phase of significant price escalation, reflecting both rising costs and intensifying demand for this high-performance material.

The European Union’s Carbon Border Adjustment Mechanism (CBAM) officially entered its full implementation phase, marking a historic shift in global trade: carbon emissions now carry a direct price tag at the border.

Sherwin-Williams Company topped TuJie’s “2025 Global Top 30 Paint & Coatings Public Companies by Market Cap” with a valuation of $80.85 billion—and just one year earlier, it had become the first paint company in history to breach the $100 billion market c

Belgian chemical giant Domo Chemicals Group quietly filed for insolvency of its three German subsidiaries—Domo Chemicals GmbH, Domo Caproleuna GmbH, and Domo Engineering Plastics GmbH—with the Halle District Court.

When iFlytek, Alipay, and Baidu each secured government healthcare AI contracts worth over RMB 100 million within a single month, the entire industry seemed to be wheeled out of the ICU and into a VIP recovery suite—breathing easier, pulse stabilizing, ey

On paper, this is a legitimate move to defend corporate reputation; in reality, it reads more like a strategic maneuver amid mounting pressure from a RMB 4 billion lawsuit and deteriorating financial performance—a small legal counteroffensive designed to